Dying with/despite a pacemaker;Sterben mit/trotz Schrittmachers

Medizinische Klinik - Intensivmedizin und Notfallmedizin

Volumn 109, Issue 1, 2014, Pages 19-26

  Reith, S ^a   Janssens, U ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b St Antonius Hospital   (Germany)

Author keywords

Defibrillators; End of life care; Ethics; Goals; Legal aspects

Indexed keywords

ARTICLE; CARDIOVASCULAR THERAPEUTIC DEVICE; CAUSE OF DEATH; HEALTH CARE PRACTICE; HUMAN; ILLNESS TRAJECTORY; INFORMED CONSENT; INTENSIVE CARE UNIT; LONG TERM CARE; MEDICAL ETHICS; PACEMAKER; PACEMAKER FAILURE; PHYSICIAN ATTITUDE; TREATMENT WITHDRAWAL; ARTIFICIAL HEART PACEMAKER; ETHICS; GERMANY; HEALTH PERSONNEL ATTITUDE; LEGISLATION AND JURISPRUDENCE; MALPRACTICE; PATIENT CARE PLANNING; TERMINAL CARE;

ATTITUDE OF HEALTH PERSONNEL; ETHICS, MEDICAL; GERMANY; HUMANS; INFORMED CONSENT; INTENSIVE CARE UNITS; MALPRACTICE; PACEMAKER, ARTIFICIAL; PATIENT CARE PLANNING; TERMINAL CARE; WITHHOLDING TREATMENT;

EID: 84894597160     PISSN: 21936218     EISSN: 21936226     Source Type: Journal    
DOI: 10.1007/s00063-013-0282-7     Document Type: Article

References (41)

1. Beauchamp TL, Childress JF (2009) Principles of biomedical ethics. Oxford University Press, New York - Oxford.
2. Beets MT, Forringer E (2011) Urgent implantable cardioverter defibrillator deactivation by unconventional means. J Pain Symptom Manage 42: 941-945.
3. Berger JT (2005) The ethics of deactivating implanted cardioverter defibrillators. Ann Intern Med 142: 631-634.
4. Camm JA, Nisam S (2010) European utilization of the implantable defibrillator: has 10 years changed the 'enigma'? Europace 2010/07/29: 1063-1069.
5. Carlsson J, Paul NW, Dann M (2012) Deaktivierung von implantierbaren Defibrillatoren. Medizinische, ethische, praktische und juristische Aspekte. Dtsch Arztebl 109: 535-541.
6. DeVita MA, Groeger J, Truog R (2003) Current controversies in critical care ethics: not just end of life. Crit Care Med 31: S343.
7. England R, England T, Coggon J (2007) The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer. J Med Ethics 33: 538-540.
8. Epstein AE, DiMarco JP, Ellenbogen KA et al (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51: 2085-2105.
9. Fromme EK, Stewart TL, Jeppesen M et al (2011) Adverse experiences with implantable defibrillators in Oregon hospices. Am J Hosp Palliat Care 28: 304-9.
10. Goldstein NE, Lampert R, Bradley E et al (2004) Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med 141: 835-838.
11. Herman D, Stros P, Curila K et al (2013) Deactivation of implantable cardioverter-defibrillators: results of patient surveys. Europace 15: 963-969.
12. Jaarsma T, Beattie JM, Ryder M et al (2009) Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 11: 433-443.
13. Janssens U, Burchardi N, Duttge G et al (2012) Therapiezieländerung und Therapiebegrenzung in der Intensivmedizin. DIVI 3: 103-107.
14. Janssens U, Karg O (2012) Sterben am/trotz Beatmungsgerät. DIVI 3: 145-155.
15. Janssens U, Reith S (2013) Der chronisch kritisch kranke Patient aus der Perspektive des Kardiologen. Med Klin Intensivmed Notfmed 108: 267-278.
16. Kay GN, Bittner GT (2009) Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction. Circ Arrhythm Electrophysiol 2: 336-9.
17. Kelley AS, Reid MC, Miller DH et al (2009) Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey. Am Heart J 157: 702-708.
18. Kobza R, Erne P (2007) End-of-life decisions in ICD patients with malignant tumors. Pacing Clin Electrophysiol 30: 845-849.
19. Kramer DB, Mitchell SL, Brock DW (2012) Deactivation of pacemakers and implantable cardioverter-defibrillators. Prog Cardiovasc Dis 55: 290-299.
20. Lampert R, Hayes DL, Annas GJ et al (2010) HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 7: 1008-1026.
21. Lanken PN, Terry PB, Delisser HM et al (2008) An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med 177: 912-927.
22. Lewis WR, Luebke DL, Johnson NJ et al (2006) Withdrawing implantable defibrillator shock therapy in terminally ill patients. Am J Med 119: 892-896.
23. Marinskis G, Erven L van, EHRA Scientific Initiatives Committee (2010) Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey. Europace 12: 1176-1177.
24. Meisel A, Snyder L, Quill T (2000) Seven legal barriers to end-of-life care: myths, realities, and grains of truth. JAMA 284: 2495-501.
25. Mueller PS, Jenkins SM, Bramstedt KA et al (2008) Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes. Pacing Clin Electrophysiol 31: 560-568.
26. Mueller PS, Swetz KM, Freeman MR et al (2010) Ethical analysis of withdrawing ventricular assist device support. Mayo Clin Proc 85: 791-797.
27. Nauck F (2011) Ethische Aspekte in der Therapie am Lebensende. Med Klin Intensivmed Notfmed 106: 137-148.
28. Padeletti L, Arnar DO, Boncinelli L et al (2010) EHRA expert consensus statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace 12: 1480-1489.
29. Paul NW (2008) Klinische Ethikberatung: Therapieziele, Patientenwille und Entscheidungsprobleme in der modernen Medizin. In T. Junginger, A. Perneczky, C.-F. Vahl, C. Werner. (Hrsg) Grenzsituationen in der Intensivemedizin. Springer, Heidelberg, S. 207-217.
30. Paul NW (2010) Clinical ethics counseling: therapeutic goals, the patient's will and decision-making problems in modern medicine Formosan Journal of Medical Humanities 11: 19-36.
31. Sherazi S, Daubert JP, Block RC et al (2008) Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator. Mayo Clin Proc 83: 1139-1141.
32. Simon A (2010) Patientenverfügung in der Intensiv- und Notfallmedizin. Intensivmed 47: 43-48.
33. Sold M, Schmidt KW (2012) Therapiebegrenzung und Therapiereduktion - praktisch umgesetzt. In: Salomon F (Hrsg) Praxisbuch ethik in der Intensivmedizin. Medizinisch Wissenschaftliche Verlagsgesellschaft, Berlin, S 247-281.
34. Sulmasy DP (2008) Within you/without you: biotechnology, ontology, and ethics. J Gen Intern Med 23: 69-72.
35. Thibodeau JB, Pillarisetti J, Khumri TM et al (2008) Mortality rates and clinical predictors of reduced survival after cardioverter defibrillator implantation. Am J Cardiol 101: 861-864.
36. Verrel T (2012) Die Rolle des Rechts bei Behandlungsentscheidungen am Lebensende. In: Salomon F (Hrsg) Praxisbuch Ethik in der Intensivmedizin. MWV, Berlin, S 95-110.
37. Vidal B, Delgado V, Mont L et al (2010) Decreased likelihood of response to cardiac resynchronization in patients with severe heart failure. Eur J Heart Fail 12: 283-287.
38. Wallner J (2010) Organisation medizinischer Entscheidungen am Lebensende. Intensivmed 47: 49-54.
39. Wilkoff BL, Auricchio A, Brugada J et al (2008) HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm 5: 907-925.
40. Wu EB (2007) The ethics of implantable devices. J Med Ethics 33: 532-533.
41. Zellner RA, Aulisio MP, Lewis WR (2009) Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating permanent pacemaker in patients with terminal illness. Patient autonomy is paramount. Circulation: Arrhythmia and Electrophysiology 2: 340-344.